Arax Advisory Partners’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
1CP
NRW
Arax Advisory Partners's BME Position: Q2 2026 in Review
Arax Advisory Partners increased its BlackRock Health Sciences Trust (BME) stake by 21% in Q2 2026, buying an estimated $3.97K and bringing the position to 579 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3803.
Arax Advisory Partners first reported a position in BME in Q3 2025 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.
- Arax Advisory Partners held 579 shares of BlackRock Health Sciences Trust worth $24.9K as of Q2 2026.
- Arax Advisory Partners bought 100 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $3.97K.
- BlackRock Health Sciences Trust made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3803 holding.
- Arax Advisory Partners first reported a position in BlackRock Health Sciences Trust in Q3 2025 and has held it in 4 quarters since.
- 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.